Advertise on podcast: The Lupus Forum

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Doctor Guillermo Pons-Estel and Professors Victoria Werth and Marta Mosca as they discuss ACR and EULAR guidance on Cutaneous and mucocutaneous manifestations of SLE, along with what that means in practice.

Doctor Guillermo J. Pons-Estel discusses a recent study evaluating anifrolumab for long-term cardiovascular damage in SLE. This podcast offers practical perspectives for clinicians looking to stay at the forefront of lupus care. To explore the full paper and download the accompanying slide deck, visit the Lupus Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: https://lupus-forum.com/

Join Professor Ed Vital and Doctors Chris Wincup, Marc Scherlinger and Melanie Hagen for this webinar on "Cell therapies in autoimmune disease: Emerging science and clinical potential". You can also find the Highlights Podcast on our website: https://lupus-forum.com/podcasts/episodes

Join Professor Ed Vital and Doctors Chris Wincup, Marc Scherlinger and Melanie Hagen on the Lupus Forum for their discussion of the recent webinar “Cell therapies in autoimmune disease: Emerging science and clinical potential”. Watch them discuss key highlights from the webinar, including exploring cell therapies in lupus, focusing on their therapeutic potential, patient selection considerations, and practical challenges to implementation in clinical practice.

Professors Ed Vital, Anca Askanase, Gavin Giovannoni and Dr Guillermo Valenzuela as they discuss key highlights from the webinar, including exploring the role of S1PR signalling in immune-mediated inflammatory diseases, the evidence supporting approved S1PR-modulating therapies, and the potential of S1PR modulation as a treatment approach for SLE.

Join Professors Ed Vital, Anca Askanase, Gavin Giovannoni and Dr Guillermo Valenzuela on the Lupus Forum for their discussion of the recent webinar “S1PR modulation: Exploring a new pathway in the treatment of lupus”. Watch them discuss key highlights from the webinar, including exploring the role of S1PR signalling in immune-mediated inflammatory diseases, the evidence supporting approved S1PR-modulating therapies, and the potential of S1PR modulation as a treatment approach for SLE.

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital, Maria Dall'Era and Marta Mosca as they discuss ACR and EULAR guidance on neuropsychiatric manifestations of lupus and lupus nephritis, along with what that means in practice.

Join Professor Ed Vital, an Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust in the UK and Professor Eric Morand, Dean of the Sub-Faculty of Clinical and Molecular Medicine at Monash University, and Head of Rheumatology at Monash Health, in Melbourne Australia, as they discuss Professor Morand’s recent paper ‘Enpatoran, a toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: Findings from cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding Phase 2 trial.’

Professor Christopher Edwards and Professor Chi-Chiu Mok discuss two recent studies advancing the treatment landscape in SLE. This episode discusses the safety of belimumab during pregnancy and the 2026 British Society for Rheumatology guideline for the management of children, young people and adults with SLE. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of lupus care. To explore the full papers and download accompanying slide decks, visit the Lupus Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: https://lupus-forum.com/

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital, Maria Dall'Era and Guillermo Pons-Estel as they discuss ACR and EULAR guidance on hematological manifestations of lupus and lupus nephritis, along with what that means in practice.

Join Ed Vital, from the University of Leeds, United Kingdom, and Marc Scherlinger, from Strasbourg University Hospital, as they discuss his recent paper ‘Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study’.

Dr Guillermo J. Pons-Estel and Professor Victoria Werth highlight the latest advances in lupus treatment. This podcast discusses the efficacy and safety of dapirolizumab pegol in patients with systemic lupus erythematosus, alongside new analyses demonstrating improved kidney outcomes with belimumab plus mycophenolate mofetil in lupus nephritis. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital and Maria Dall'Era as they take a closer look at the ACR and EULAR guideline development models and consider their methodological strengths and differences, and point to additional resources.

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses real-world effectiveness of anifrolumab in moderate-to-severe SLE and belimumab in SLE with haematological manifestations. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of lupus care. To explore the full papers and download accompanying slide decks, visit the Lupus Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: https://lupus-forum.com/

Join Professor Ed Vital as he reviews his highlights from the recent EULAR 2026 congress and discusses key abstracts and findings.